ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Canon enters regenerative medicine with cell therapy acquisition

Manufacturer seeks to blend AI imaging with culturing tech to lower cost barriers

A scientist prepares stem cells at a British lab. Regenerative therapy is on track to become an $11 billion market by 2028.   © Reuters

TOKYO -- Canon is adding cell culturing to its medical business portfolio, leveraging technology from its camera business to improve efficiency in a key area for the burgeoning field of regenerative medicine.

The Japanese manufacturer has agreed to acquire the cell culture operations of packing equipment maker Kyoto Seisakusho, including its patents, for an undisclosed amount in a deal expected to be completed by mid-May.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more